BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19523340)

  • 1. Growth factor coinjection improves the migration potential of monkey myogenic precursors without affecting cell transplantation success.
    Lafreniere JF; Caron MC; Skuk D; Goulet M; Cheikh AR; Tremblay JP
    Cell Transplant; 2009; 18(7):719-30. PubMed ID: 19523340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful myoblast transplantation in primates depends on appropriate cell delivery and induction of regeneration in the host muscle.
    Skuk D; Roy B; Goulet M; Tremblay JP
    Exp Neurol; 1999 Jan; 155(1):22-30. PubMed ID: 9918701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new pro-migratory activity on human myogenic precursor cells for a synthetic peptide within the E domain of the mechano growth factor.
    Mills P; Lafrenière JF; Benabdallah BF; El Fahime el M; Tremblay JP
    Exp Cell Res; 2007 Feb; 313(3):527-37. PubMed ID: 17156777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth factors improve the in vivo migration of human skeletal myoblasts by modulating their endogenous proteolytic activity.
    Lafreniere JF; Mills P; Tremblay JP; El Fahime E
    Transplantation; 2004 Jun; 77(11):1741-7. PubMed ID: 15201676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplanted myoblasts can migrate several millimeters to fuse with damaged myofibers in nonhuman primate skeletal muscle.
    Skuk D; Goulet M; Tremblay JP
    J Neuropathol Exp Neurol; 2011 Sep; 70(9):770-8. PubMed ID: 21865885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of follistatin in human myoblasts increases their proliferation and differentiation, and improves the graft success in SCID mice.
    Benabdallah BF; Bouchentouf M; Rousseau J; Tremblay JP
    Cell Transplant; 2009; 18(7):709-18. PubMed ID: 19520047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-4 improves the migration of human myogenic precursor cells in vitro and in vivo.
    Lafreniere JF; Mills P; Bouchentouf M; Tremblay JP
    Exp Cell Res; 2006 Apr; 312(7):1127-41. PubMed ID: 16466711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth factor supplemented matrigel improves ectopic skeletal muscle formation--a cell therapy approach.
    Barbero A; Benelli R; Minghelli S; Tosetti F; Dorcaratto A; Ponzetto C; Wernig A; Cullen MJ; Albini A; Noonan DM
    J Cell Physiol; 2001 Feb; 186(2):183-92. PubMed ID: 11169455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of MyoD increases donor myoblast migration into host muscle.
    Smythe GM; Grounds MD
    Exp Cell Res; 2001 Jul; 267(2):267-74. PubMed ID: 11426945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exercise improves the success of myoblast transplantation in mdx mice.
    Bouchentouf M; Benabdallah BF; Mills P; Tremblay JP
    Neuromuscul Disord; 2006 Aug; 16(8):518-29. PubMed ID: 16919954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial failure in myoblast transplantation therapy has led the way toward the isolation of muscle stem cells: potential for tissue regeneration.
    Urish K; Kanda Y; Huard J
    Curr Top Dev Biol; 2005; 68():263-80. PubMed ID: 16125002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment of myoblast cultures with basic fibroblast growth factor increases the efficacy of their transplantation in mdx mice.
    Kinoshita I; Vilquin JT; Tremblay JP
    Muscle Nerve; 1995 Aug; 18(8):834-41. PubMed ID: 7630343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matching host muscle and donor myoblasts for myosin heavy chain improves myoblast transfer therapy.
    Qu Z; Huard J
    Gene Ther; 2000 Mar; 7(5):428-37. PubMed ID: 10694825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in myoblast transplantation: a potential treatment of dystrophies.
    Skuk D; Tremblay JP
    Microsc Res Tech; 2000 Feb 1-15; 48(3-4):213-22. PubMed ID: 10679968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The survival of myoblasts after intramuscular transplantation is improved when fewer cells are injected.
    Pellegrini KL; Beilharz MW
    Transplantation; 2011 Mar; 91(5):522-6. PubMed ID: 21192317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dystrophin expression in muscles of duchenne muscular dystrophy patients after high-density injections of normal myogenic cells.
    Skuk D; Goulet M; Roy B; Chapdelaine P; Bouchard JP; Roy R; Dugré FJ; Sylvain M; Lachance JG; Deschênes L; Senay H; Tremblay JP
    J Neuropathol Exp Neurol; 2006 Apr; 65(4):371-86. PubMed ID: 16691118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocyte growth factor/scatter factor stimulates migration of muscle precursors in developing mouse tongue.
    Bandow K; Ohnishi T; Tamura M; Semba I; Daikuhara Y
    J Cell Physiol; 2004 Nov; 201(2):236-43. PubMed ID: 15334658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intramuscular migration of myoblasts transplanted after muscle pretreatment with metalloproteinases.
    Torrente Y; El Fahime E; Caron NJ; Bresolin N; Tremblay JP
    Cell Transplant; 2000; 9(4):539-49. PubMed ID: 11038070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy of Duchenne muscular dystrophy with umbilical cord blood stem cell transplantation].
    Zhang C; Feng HY; Huang SL; Fang JP; Xiao LL; Yao XL; Chen C; Ye X; Zeng Y; Lu XL; Wen JM; Zhang WX; Li Z; Feng SW; Xu HG; Huang K; Zhou DH; Chen W; Xie YM; Xi J; Zhang M; Li Y; Liu Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Aug; 22(4):399-405. PubMed ID: 16086277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the developmental fate of cultured and noncultured myoblasts when transplanted into embryonic limbs.
    DiMario JX; Stockdale FE
    Exp Cell Res; 1995 Feb; 216(2):431-42. PubMed ID: 7843288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.